Skip to main content
ResMed Inc. (ASX: RMD)
Australia flag Australia · Delayed Price · Currency is AUD
36.81
-0.12 (-0.32%)
Dec 20, 2024, 4:10 PM AEST

ResMed Revenue

ResMed had revenue of $1.22B USD in the quarter ending September 30, 2024, with 11.08% growth. This brings the company's revenue in the last twelve months to $4.81B, up 9.88% year-over-year. In the fiscal year ending June 30, 2024, ResMed had annual revenue of $4.69B with 10.95% growth.

Revenue (ttm)
$4.81B
Revenue Growth
+9.88%
P/S Ratio
n/a
Revenue / Employee
$481.71K
Employees
9,980
Market Cap
55.68B AUD

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20244.69B462.30M10.95%
Jun 30, 20234.22B644.87M18.02%
Jun 30, 20223.58B381.30M11.93%
Jun 30, 20213.20B239.81M8.11%
Jun 30, 20202.96B350.44M13.44%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 22.18B
Pro Medicus Limited 161.50M
Fisher & Paykel Healthcare Corporation Limited 1.74B
Cochlear Limited 2.24B
Sonic Healthcare Limited 8.97B
Telix Pharmaceuticals Limited 645.68M
Ramsay Health Care Limited 16.66B
Neuren Pharmaceuticals Limited 193.34M
Revenue Rankings

ResMed News

More News